- Home
- INTS vs APWC Comparison
INTS vs APWC Comparison
Compare INTS & APWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- APWC
- Stock Information
- Founded
- INTS 2012
- APWC 1996
- Country
- INTS United States
- APWC Taiwan
- Employees
- INTS N/A
- APWC N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- APWC Telecommunications Equipment
- Sector
- INTS Health Care
- APWC Industrials
- Exchange
- INTS Nasdaq
- APWC Nasdaq
- Market Cap
- INTS 30.8M
- APWC 30.1M
- IPO Year
- INTS 2023
- APWC 1997
- Fundamental
- Price
- INTS $1.30
- APWC $1.56
- Analyst Decision
- INTS Strong Buy
- APWC
- Analyst Count
- INTS 3
- APWC 0
- Target Price
- INTS $8.50
- APWC N/A
- AVG Volume (30 Days)
- INTS 37.8K
- APWC 3.3K
- Earning Date
- INTS 05-08-2025
- APWC 03-31-2025
- Dividend Yield
- INTS N/A
- APWC N/A
- EPS Growth
- INTS N/A
- APWC N/A
- EPS
- INTS N/A
- APWC 0.17
- Revenue
- INTS N/A
- APWC $472,672,000.00
- Revenue This Year
- INTS N/A
- APWC N/A
- Revenue Next Year
- INTS N/A
- APWC N/A
- P/E Ratio
- INTS N/A
- APWC $9.46
- Revenue Growth
- INTS N/A
- APWC 11.02
- 52 Week Low
- INTS $1.27
- APWC $1.24
- 52 Week High
- INTS $5.28
- APWC $2.02
- Technical
- Relative Strength Index (RSI)
- INTS 22.77
- APWC 50.70
- Support Level
- INTS $1.78
- APWC $1.55
- Resistance Level
- INTS $1.94
- APWC $1.65
- Average True Range (ATR)
- INTS 0.17
- APWC 0.07
- MACD
- INTS -0.03
- APWC 0.01
- Stochastic Oscillator
- INTS 4.10
- APWC 55.00
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.